Image of hemp oil products told by FDA to stop making medical promises
~
WASHINGTON, DC — The Food and Drug Administration (FDA) has sent letters to several makers of cannabidiol (CBD) oils derived from hemp, telling them to stop making medical claims about their products’ ability to treat disease.
 
Many sellers of hemp-based cannabidiol products, who advertise their products as “legal in all 50 states” because they are derived from industrial hemp, have been making claims that their products are rich in cannabidiol (CBD) and can be used for “the diagnosis, cure, mitigation, treatment, or prevention of diseases,” according to the FDA.
 
The FDA, which considers CBD an “unapproved new drug,” says these companies are mis-branding the products and issuing false claims to consumers.  Often these products do not even list their ingredients on the product label, the FDA added.
 
“Consumers should beware purchasing and using any such products,” the FDA says.  “It is important to note that these products are not approved by FDA for the diagnosis, cure, mitigation, treatment, or prevention of any disease.”
 
In late February, the FDA issued several warning letters to seven companies that manufacture and market hemp oils claiming to be “rich in CBD.”  By promising cures for conditions such as cancer, autism and epilepsy — none of which have been tested by the FDA — the companies who were issued warning letters appear to be violating food and drug labeling laws.
 
In some cases, the companies could not even spell “cannabidiol” or “inflammation” correctly, the FDA notes.
 
The following companies and products were among those notified by the FDA (with hyperlinks opening each company’s letter in a new window):   Cancerherbtea.com of Florida; CBD Life Holdings, LLC (makers of Ultra CBD) of Arizona; Hemp Oil Care of California; PureCBD.net of Washington; Twin Falls Bio Tech of South Carolina; Canna Companion of Washington; and Canna Pet of Washington.
 
The FDA also conducted tests of some products sold by these companies, and found found that in most cases, the products contained very little cannabidiol — or none at all:
  •  
  • -The FDA tested two separate samples of “UltraCBD,” sold by CBD Life Holdings LLC (a one ounce bottle costs $45 on their website or Amazon).  Of the samples tested, one did not contain any cannabinoids — CBD or otherwise — while the  second contained only .02% CBD.  Of all products tested by the FDA that were found to contain some CBD, the “UltraCBD” products contained the smallest percentage.
  • -The FDA tested seven products sold by California-based Hemp Oil Care.  Of the products tested, three products — Hemp Pure Vape E-Drops: Peached, ‘Hemp Honey 21% Cannabidiol Oil’, and Hemp Honey CBD Vape Oil – Blueberries &  Cream all tested negative for cannabinoids.  Three flavors of Cibdex Hemp CBD Complex Drops (peppermint, unflavored and vanilla) all contained .3% CBD.  The final product tested, Cibaderm Hemp Salve contained no CBD but did contain  .2% cannabidiolic acid (CBDA).
  • -The FDA tested four products offered by Natural Organic Solutions and sold at purecbd.net.  Two of those products, “CBD Oil Extract Capsules (500mg – 10 Capsules)” and “21% CBD Hemp Oil Treatment” tested negative for cannabinoids.  Of  the remaining two products tested, “Real CBD Extract – CBD (Cannabidiol) Cannabis Extract Capsules (1500mg – 30 Capsules)” contained .5% CBD, .2% THC (tetrahydrocannabinol), .1% CBDA, .03% THCA (tetrahydrocannabinol acid);  while their “26% CBD Hemp Oil Treatment” was found to contain .14% CBD, .45% THC, and .05% CBDA.
  • -The FDA tested Arisi-Tol, made by Twin Falls Bio Tech LLC, and found that their product, which sells for $99.95 for a one month supply, contained .2% CBD.
  • -The FDA also tested two manufacturers of CBD products marketed for pets.  From Washington-based Canna Companion LLC, the FDA tested “Canna Companion Capsule Size: 4″ and found that the product contained .1% CBD, .1% THC, .3%  CBDA and .9% THCA.   Three products from Canna-Pet LLC were also tested, with “CBD Wedges – Canna-Biscuits for Dogs” testing negative for cannabinoids, “Canna-Pet for Cats” containing .5% CBD, and “Canna-Pet MaxCBD Capsules  for Dogs” containing 2.6% CBD (the highest percentage of all test results), .1% THC, and .1% CBC (cannabichromene).
 
The warned CBD companies have fifteen days to show the FDA how they are complying with the warning letters. “Failure to promptly correct these violations may result in legal action without further notice, including, without limitation, seizure and/or injunction,” the FDA warns.
 
Medical marijuana experts suggest patients considering CBD treatment to instead seek CBD-rich strains of cannabis grown in states that allow medical marijuana, such as Colorado, who also require independent labratory testing of all marijuana products.
 
~
July 15, 2019

FDA Says It Is Speeding Up The…

The Food and Drug Administration (FDA) said on Friday that it was “expediting” its efforts to develop rules for CBD…
July 15, 2019

Univ. of Florida agricultural researchers cultivate industrial…

With the help of state lawmakers, industrial hemp is now a growing crop across the state of Florida. A new…
July 15, 2019

Cannabis helped mother go from bedridden to…

Melissa Vincent credits medical cannabis with allowing her to reconnect with her real self and her family.
July 15, 2019

Medical cannabis is gaining momentum in Asia…

With Thailand’s legalization of medical cannabis in February, some experts predict that other Southeast Asian countries may move to decriminalize…
July 12, 2019

Anxiety now qualifies for medical marijuana in…

The Pennsylvania Department of Health on Thursday added anxiety disorders and Tourette’s syndrome to the list of health conditions that…
July 12, 2019

Oregon Marijuana Surplus a Cautionary Tale for…

Five years after Oregon legalized recreational marijuana, its lawmakers now are trying to rein in production, fearing the state’s big…
July 12, 2019

US govt. growing largest crop of marijuana…

The U.S. government is growing the largest crop of research marijuana in five years, responding to interest in varieties with…
July 12, 2019

Why Cannabis Buyers Are Uniquely Vulnerable to…

Experts in the field of cyber security say North America’s emerging cannabis industry -- and its customers -- could be…
July 11, 2019

Growing Cannabis in Vermont, One Year After…

The law went into effect a year ago this month, making it legal for Vermonters over 21 and without a…
July 11, 2019

Why This Decades-Old Skincare Line is Now…

"My whole life lately seems to be about hemp," says Lily Morgan.
July 11, 2019

Is Medical Marijuana the Solution to the…

Studies suggest that medical cannabis might be an effective PTSD treatment. The VA has come out against bills that would…